Clinical Trial Update: Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach, gastroesophageal junction, or esoph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagus
• Adenocarcinoma of the Gastroesophageal Junction
• Adenocarcinoma of the Stomach

Drugs mentioned

• Adriamycin (doxorubicin)
• Adrucil (5-fluorouracil)
• Platinol (cisplatin)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Adenocarcinoma of Stomach, Adenocarcinoma of GE Junction | Phase 2 | Status: COMPLETED